These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 21791872)

  • 1. Association between cancer risk and drug-metabolizing enzyme gene (CYP2A6, CYP2A13, CYP4B1, SULT1A1, GSTM1, and GSTT1) polymorphisms in cases of lung cancer in Japan.
    Tamaki Y; Arai T; Sugimura H; Sasaki T; Honda M; Muroi Y; Matsubara Y; Kanno S; Ishikawa M; Hirasawa N; Hiratsuka M
    Drug Metab Pharmacokinet; 2011; 26(5):516-22. PubMed ID: 21791872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of NAT2, GSTM1, GSTT1, CYP2A6, and CYP2A13 gene polymorphisms with susceptibility and clinicopathologic characteristics of bladder cancer in Central China.
    Song DK; Xing DL; Zhang LR; Li ZX; Liu J; Qiao BP
    Cancer Detect Prev; 2009; 32(5-6):416-23. PubMed ID: 19303722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Independent and Interactive Effect of CYPs and GSTs Genetic Variants and Tobacco Smoking on the Risk of Non-Small Cell Lung Carcinoma.
    Pathak AK; Husain N; Kant S; Bala L
    Arch Med Res; 2021 Oct; 52(7):719-730. PubMed ID: 34092421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substantial reduction in risk of lung adenocarcinoma associated with genetic polymorphism in CYP2A13, the most active cytochrome P450 for the metabolic activation of tobacco-specific carcinogen NNK.
    Wang H; Tan W; Hao B; Miao X; Zhou G; He F; Lin D
    Cancer Res; 2003 Nov; 63(22):8057-61. PubMed ID: 14633739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GSTM1, GSTT1, and GSTP1 polymorphism and lung cancer risk in relation to tobacco smoking.
    Schneider J; Bernges U; Philipp M; Woitowitz HJ
    Cancer Lett; 2004 May; 208(1):65-74. PubMed ID: 15105047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms of GSTP1 and GSTT1, but not of CYP2A6, CYP2E1 or GSTM1, modify the risk for esophageal cancer in a western population.
    Rossini A; Rapozo DC; Soares Lima SC; Guimarães DP; Ferreira MA; Teixeira R; Kruel CD; Barros SG; Andreollo NA; Acatauassú R; Matos HJ; Albano RM; Pinto LF
    Carcinogenesis; 2007 Dec; 28(12):2537-42. PubMed ID: 17916905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CYP1A1 (Ile462Val), CYP1B1 (Ala119Ser and Val432Leu), GSTM1 (null), and GSTT1 (null) polymorphisms and bladder cancer risk in a Turkish population.
    Berber U; Yilmaz I; Yilmaz O; Haholu A; Kucukodaci Z; Ates F; Demirel D
    Asian Pac J Cancer Prev; 2013; 14(6):3925-9. PubMed ID: 23886208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GST, NAT, SULT1A1, CYP1B1 genetic polymorphisms, interactions with environmental exposures and bladder cancer risk in a high-risk population.
    Hung RJ; Boffetta P; Brennan P; Malaveille C; Hautefeuille A; Donato F; Gelatti U; Spaliviero M; Placidi D; Carta A; Scotto di Carlo A; Porru S
    Int J Cancer; 2004 Jul; 110(4):598-604. PubMed ID: 15122594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glutathione S-transferase M1 (GSTM1) and T1 (GSTT1) Polymorphisms and Lung Cancer Risk among a Select Group of Iranian People.
    Adibhesami G; Shahsavari GR; Amiri A; Emami Razavi AN; Shamaei M; Birjandi M
    Asian Pac J Cancer Prev; 2018 Oct; 19(10):2921-2927. PubMed ID: 30362324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic polymorphism of glutathione S-transferases M1 and T1 as a risk factor in lung and bladder cancers.
    Salagovic J; Kalina I; Stubna J; Habalová V; Hrivnák M; Valanský L; Kohút A; Biros E
    Neoplasma; 1998; 45(5):312-7. PubMed ID: 9921921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CYP1A1, GSTM1 and GSTT1 genetic polymorphisms and gastric cancer risk among Japanese: A nested case-control study within a large-scale population-based prospective study.
    Hidaka A; Sasazuki S; Matsuo K; Ito H; Charvat H; Sawada N; Shimazu T; Yamaji T; Iwasaki M; Inoue M; Tsugane S;
    Int J Cancer; 2016 Aug; 139(4):759-68. PubMed ID: 27062139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glutathione-S-Transferase M1 and codon 72 p53 polymorphisms in a northwestern Mediterranean population and their relation to lung cancer susceptibility.
    To-Figueras J; Gene M; Gomez-Catalan J; Galan C; Firvida J; Fuentes M; Rodamilans M; Huguet E; Estape J; Corbella J
    Cancer Epidemiol Biomarkers Prev; 1996 May; 5(5):337-42. PubMed ID: 9162298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency of CYP2A6 gene deletion and its relation to risk of lung and esophageal cancer in the Chinese population.
    Tan W; Chen GF; Xing DY; Song CY; Kadlubar FF; Lin DX
    Int J Cancer; 2001 Mar; 95(2):96-101. PubMed ID: 11241319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glutathione-S-transferase M1, M3, T1 and P1 polymorphisms and susceptibility to non-small-cell lung cancer subtypes and hamartomas.
    Risch A; Wikman H; Thiel S; Schmezer P; Edler L; Drings P; Dienemann H; Kayser K; Schulz V; Spiegelhalder B; Bartsch H
    Pharmacogenetics; 2001 Dec; 11(9):757-64. PubMed ID: 11740339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between genetic polymorphisms of drug-metabolizing enzymes (CYP1A1, CYP2E1, GSTM1, and NAT2), drinking habits, histological subtypes, and p53 gene point mutations in Japanese patients with gastric cancer.
    Suzuki S; Muroishi Y; Nakanishi I; Oda Y
    J Gastroenterol; 2004; 39(3):220-30. PubMed ID: 15064998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility of lung cancer with polymorphisms of CYP1A1, GSTM1, GSTM3, GSTT1 and GSTP1 genotypes in the population of Inner Mongolia region.
    Jiang XY; Chang FH; Bai TY; Lv XL; Wang MJ
    Asian Pac J Cancer Prev; 2014; 15(13):5207-14. PubMed ID: 25040976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of genetic polymorphism of glutathione S-transferase (GSTM1, GSTT1, GSTP1) with bladder cancer susceptibility.
    Safarinejad MR; Safarinejad S; Shafiei N; Safarinejad S
    Urol Oncol; 2013 Oct; 31(7):1193-203. PubMed ID: 22154357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Associations between genetic polymorphisms of glutathione S-transferase M1 and T1, smoking and susceptibility to colorectal cancer: a case-control study].
    Chen K; Jiang QT; Ma XY; Yao KY; Leng SG; Yu WP; Zhou HG
    Zhonghua Zhong Liu Za Zhi; 2004 Nov; 26(11):645-8. PubMed ID: 15777499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GSTA1, GSTM1, GSTP1, and GSTT1 polymorphisms and susceptibility to smoking-related bladder cancer: a case-control study.
    Matic M; Pekmezovic T; Djukic T; Mimic-Oka J; Dragicevic D; Krivic B; Suvakov S; Savic-Radojevic A; Pljesa-Ercegovac M; Tulic C; Coric V; Simic T
    Urol Oncol; 2013 Oct; 31(7):1184-92. PubMed ID: 24075358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glutathione S-transferase M1 and T1 polymorphisms: susceptibility and outcomes in muscle invasive bladder cancer patients.
    Kang HW; Song PH; Ha YS; Kim WT; Kim YJ; Yun SJ; Lee SC; Choi YH; Moon SK; Kim WJ
    Eur J Cancer; 2013 Sep; 49(14):3010-9. PubMed ID: 23810248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.